Literature DB >> 32428905

Short-Term Psychodynamic Psychotherapy for Functional Somatic Disorders: A Meta-Analysis of Randomized Controlled Trials.

Allan Abbass1, Joel Town2, Hannah Holmes3, Patrick Luyten4,5, Angela Cooper2, Leo Russell6, Mark A Lumley3, Howard Schubiner7, Jenny Allinson8, Denise Bernier2, Celine De Meulemeester4, Kurt Kroenke9, Steve Kisely2,10.   

Abstract

INTRODUCTION: Functionalsomatic disorders (FSD) are common and costly, thereby driving the need for the development of effective brief treatment options. Short-term psychodynamic psychotherapy (STPP) is one candidate treatment method.
OBJECTIVE: To review and meta-analyze, where possible, randomized controlled trials (RCTs) of STPP for FSD.
METHODS: Following a systematic search of the literature, we performed a meta-analysis of available RCT groups to determine the effects of STPP on a range of outcomes after treatment, and medium- and long-term follow-ups.
RESULTS: In meta-analyses of 17 RCTs, STPP significantly outperformed minimal treatment, treatment as usual, or waiting list controls on somatic symptom measures at all time frames, with small to large magnitude effect sizes. Descriptive reviews of 5 RCTs suggest that STPP performed at least as well as other bona fide psychological therapies. Limitations of this meta-analysis include small samples of studies and possible publication bias.
CONCLUSIONS: STPP is a valid treatment option for diverse FSD conditions resulting in somatic symptom reductions that persist over time. STPP should be included in FSD treatment guidelines.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Alexithymia; Emotion; Functional somatic disorders; Medically unexplained symptoms; Short-term psychodynamic psychotherapy; Somatic symptom disorders; Somatization; Somatoform disorders

Mesh:

Year:  2020        PMID: 32428905     DOI: 10.1159/000507738

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  5 in total

Review 1.  Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use.

Authors:  Rachel V Aaron; Patrick H Finan; Stephen T Wegener; Francis J Keefe; Mark A Lumley
Journal:  Am Psychol       Date:  2020-09

Review 2.  Emotional awareness and other emotional processes: implications for the assessment and treatment of chronic pain.

Authors:  Mark A Lumley; Shoshana Krohner; Liyah M Marshall; Torran C Kitts; Howard Schubiner; Brandon C Yarns
Journal:  Pain Manag       Date:  2021-02-03

3.  Alexithymia is a determinant of early death in the long-term course of post-myocardial infarction.

Authors:  Mauro Giovanni Carta; Federica Sancassiani; Davide Bina; Marco Licciardi; Giulia Cossu; Antonio Egidio Nardi; Luigi Meloni; Roberta Montisci
Journal:  J Public Health Res       Date:  2022-03-16

4.  The capacity to adapt: Documenting the relationship between stressors and probable depression, anxiety, and posttraumatic stress at two time points during the COVID-19 pandemic.

Authors:  Sasha Rudenstine; Talia Schulder; Krish J Bhatt; Kat McNeal; Catherine K Ettman; Sandro Galea
Journal:  J Affect Disord       Date:  2022-08-30       Impact factor: 6.533

5.  Early Psychological Interventions for Somatic Symptom Disorder and Functional Somatic Syndromes: A Systematic Review and Meta-Analysis.

Authors:  Lukas Berezowski; Lea Ludwig; Alexandra Martin; Bernd Löwe; Meike C Shedden-Mora
Journal:  Psychosom Med       Date:  2022-04-01       Impact factor: 4.312

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.